ATTRUBY
Live / Registered — Registered (as of 03 Jun 2025)
What this means for you
Registered since 03 Jun 2025. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 03 Jun 2031: the §8 declaration of use).
Record
- Serial number
- 97288153
- Registration number
- 7819464
- Mark type
- Word mark
- Filed
- 28 Feb 2022
- Published for opposition
- 17 Jan 2023
- Registered
- 03 Jun 2025
- Next maintenance filing
- §8 declaration of use, due by 03 Jun 2031 (grace period to 03 Dec 2031)
- Attorney of record
- Joyce M. Ferraro
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for use in the treatment of oncological, cardiological, dermatological, neurological, genetic, orthopedic and metabolic diseases and disorders
Owner
- BridgeBio Pharma, Inc., Palo Alto, CA, US
- BridgeBio Pharma, Inc., Palo Alto, CA, US
- BridgeBio Pharma, Inc., Palo Alto, CA, US
Prosecution history
- 15 Sept 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 15 Sept 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 15 Sept 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 15 Sept 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 15 Sept 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 03 Jun 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 03 Jun 2025 — REGISTERED-PRINCIPAL REGISTER
- 09 May 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 09 May 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 16 Apr 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 05 Feb 2025 — USE AMENDMENT FILED
- 16 Apr 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 06 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Feb 2025 — TEAS STATEMENT OF USE RECEIVED
- 06 Feb 2025 — SOU EXTENSION 4 GRANTED